Hemodynamic Monitoring Better Than Hypertensive Drugs

A variety of agents were prescribed, including angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, beta-blockers, calcium channel blockers, and diuretics. At the end of the study period, systolic blood pressure reductions were greater in the hemodynamic-monitoring group than those who had standard therapy. This was true compared to baseline (19 mm Hg versus 11 mm Hg), and after washout (25 mm Hg versus 19 mm Hg). A similar pattern of diastolic blood pressure reductions were seen on comparison to baseline measurements (12 mm Hg versus 5 mm Hg) and after washout (17 mm Hg versus 10 mm Hg). The results were reported in the April 2006 issue of Hypertension

"Impedance cardiography has emerged as a reliable noninvasive method to measure hemodynamics in physician offices,” said senior investigator Dr. Carlos M. Ferrario, of Wake Forest University School of Medicine. "Using the system to treat hypertension could significantly improve blood pressure control.”

The researchers used the BioZ monitor, manufactured by CardioDynamics (San Diego, CA, USA), a noninvasive hemodynamic monitor that measures thoracic impedance via four dual sensors. The monitor features proprietary DISQ (Digital Impedance Signal Quantifier) technology and an innovative algorithm that processes impedance changes and calculates hemodynamic parameters, including cardiac output, systemic vascular resistance, contractility, and fluid status.



Related Links:
Wake Forest University School of Medicine
CardioDynamics